anesthesia, anesthesiology, critical care medicine, education, electronic publication, intensive care medicine, internet, multimedia, online, peer-review, regional anesthesia, trauma
. Questions and Answers. The Internet Journal of Anesthesiology. 1998 Volume 3 Number 2.
This site was created in order to stress your brain for a few minutes (3 questions) while surfing by. Every once in a while we will update this section with new questions and answers. This will give you the opportunity to check your knowledge in different anesthesiologic fields. If you would like to be informed whenever we update this section please subscribe for free as reader of The Internet Journal of Anesthesiology.
One should keep in mind that the current opinion in Europe may differ from the one in Australia or in the U.S. Having an international readership, it might be difficult to satisfy everybody with the given answers or the suggestions for additional reading. In order to assure the accuracy of this section, all the questions and especially the answers will be reviewed by several international members of the editorial board. Nevertheless, it is difficult to ensure that all the information given is entirely accurate for all circumstances. The publishers disclaim any liability, loss, or damage occurred as consequence, directly or indirectly, of the use and application of any of the content of this section.
What are the symptoms or complications of a "TURP-Syndrome"?
What kind of a drug is corlopam (fenoldopam mesylate) ?
The feeding tube is placed in the right mainstem bronchus.
Symptoms or complications of a "TURP-Syndrome" are:
Corlopam (Fenoldopam) is a relatively new peripheral dopamine-1 (DA1) receptor agonist. It decreases blood pressure by dilating renal, splanchnic and cardiac vasculature. There is good evidence that corlopam not only lowers blood pressure, but also improves renal function.
Please check our future issues of The Internet Journal of Anesthesiology for a more detailed article (by Sheinbaum R, Reyna R, and Wenker O) on this new drug.